FDA Watch: DOGE Changes at FDA Upend Approval Processes, Observers Say
Pre-submission and Q-Submission meetings apparently have been halted, for now
Pre-submission and Q-Submission meetings apparently have been halted, for now
The 2025 CLFS update—what has changed, what has stayed the same, and what that means for diagnostic test reimbursement in 2025
How automation, artificial intelligence, and other emerging technologies are elevating the efficiency and output of labs’ revenue cycles
With the rule recently struck down by a Texas court, how should employers, including labs, handle such agreements going forward?
A PT update went into effect on January 1, focusing on revised acceptance limits, among other modifications
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
Earle S. Collum, chair of the CAP Council on Accreditation, talks through regulatory changes in 2024 and what to expect from 2025
What challenges and opportunities affected the experience of medical lab professionals in 2024—and what might the new year bring?
Experts say new leadership could impact the cost and availability of IVDs as well as patients’ ability to afford lab testing
Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond
Cases filed or resolved by the U.S. Department of Justice in the fourth quarter reveal the same compliance issues from early in 2024